Health Catalyst, Inc Common Stock (HCAT) is a publicly traded Healthcare sector company. As of August 10, 2026, HCAT trades at $1.72 with a market cap of $127.84M and a P/E ratio of -0.47. HCAT moved -25.32% today. Year to date, HCAT is -27.62%; over the trailing twelve months it is -53.12%. Its 52-week range spans $0.96 to $8.00. Analyst consensus is neutral with an average price target of $2.17. Rallies surfaces HCAT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for HCAT, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $1.72 |
| Market Cap | $127.84M |
| P/E Ratio | -0.47 |
| EPS | $-3.70 |
| Dividend Yield | 0.00% |
| 52-Week High | $8.00 |
| 52-Week Low | $0.96 |
| Volume | 3.01M |
| Avg Volume | 0 |
| Revenue (TTM) | $292.25M |
| Net Income | $-264.82M |
| Gross Margin | 0.00% |
8 analysts cover HCAT: 0 strong buy, 2 buy, 6 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $2.17.